Cargando…

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans

Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports est...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fagundo, Ana B., de la Torre, Rafael, Jiménez-Murcia, Susana, Agüera, Zaida, Pastor, Antoni, Casanueva, Felipe F., Granero, Roser, Baños, Rosa, Botella, Cristina, del Pino-Gutierrez, Amparo, Fernández-Real, Jose M., Fernández-García, Jose C., Frühbeck, Gema, Gómez-Ambrosi, Javier, Menchón, José M., Moragrega, Inés, Rodríguez, Roser, Tárrega, Salomé, Tinahones, Francisco J., Fernández-Aranda, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686875/ https://www.ncbi.nlm.nih.gov/pubmed/23840456 http://dx.doi.org/10.1371/journal.pone.0066387

Ejemplares similares

A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women
por: Pastor, Antoni, et al.
Publicado: (2016)

Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament
por: Fernández-Aranda, Fernando, et al.
Publicado: (2014)

Executive Functions Profile in Extreme Eating/Weight Conditions: From Anorexia Nervosa to Obesity
por: Fagundo, Ana B., et al.
Publicado: (2012)

Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor
por: Shim, Joong-Youn
Publicado: (2021)

Modulation of Higher-Order Olfaction Components on Executive Functions in Humans
por: Fagundo, Ana B., et al.
Publicado: (2015)

Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
por: Pardo, María, et al.
Publicado: (2014)

The Relationship between Non-Suicidal Self-Injury and the UPPS-P Impulsivity Facets in Eating Disorders and Healthy Controls
por: Claes, Laurence, et al.
Publicado: (2015)

Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment Outcome
por: Agüera, Zaida, et al.
Publicado: (2015)

Olfaction in eating disorders and abnormal eating behavior: a systematic review
por: Islam, Mohammed A., et al.
Publicado: (2015)

Emotion regulation in disordered eating: Psychometric properties of the Difficulties in Emotion Regulation Scale among Spanish adults and its interrelations with personality and clinical severity
por: Wolz, Ines, et al.
Publicado: (2015)

An increase in visceral fat is associated with a decrease in the taste and olfactory capacity
por: Fernandez-Garcia, Jose Carlos, et al.
Publicado: (2017)

Correction: An increase in visceral fat is associated with a decrease in the taste and olfactory capacity
por: Fernandez-Garcia, Jose Carlos, et al.
Publicado: (2017)

Decision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?
por: Mallorquí-Bagué, Nuria, et al.
Publicado: (2016)

Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa
por: Steward, Trevor, et al.
Publicado: (2019)

Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity
por: Fagundo, A. B., et al.
Publicado: (2016)

Correlates of Non-suicidal Self-Injury and Suicide Attempts in Bulimic Spectrum Disorders
por: Gómez-Expósito, Alexandra, et al.
Publicado: (2016)

ADHD symptomatology in eating disorders: a secondary psychopathological measure of severity?
por: Fernández-Aranda, Fernando, et al.
Publicado: (2013)

Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity
por: Baenas, Isabel, et al.
Publicado: (2023)

Lifetime Obesity in Patients with Eating Disorders: Increasing Prevalence, Clinical and Personality Correlates
por: Villarejo, Cynthia, et al.
Publicado: (2012)

Lifetime Weight Course as a Phenotypic Marker of Severity and Therapeutic Response in Patients with Eating Disorders
por: Agüera, Zaida, et al.
Publicado: (2021)

Food Addiction in Gambling Disorder: Frequency and Clinical Outcomes
por: Jiménez-Murcia, Susana, et al.
Publicado: (2017)

Cognitive behaviour therapy response and dropout rate across purging and nonpurging bulimia nervosa and binge eating disorder: DSM-5 implications
por: Agüera, Zaida, et al.
Publicado: (2013)

Dimensions of Compulsive Exercise across Eating Disorder Diagnostic Subtypes and the Validation of the Spanish Version of the Compulsive Exercise Test
por: Sauchelli, Sarah, et al.
Publicado: (2016)

“Food Addiction” in Patients with Eating Disorders is Associated with Negative Urgency and Difficulties to Focus on Long-Term Goals
por: Wolz, Ines, et al.
Publicado: (2016)

Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
por: Custal, Nuria, et al.
Publicado: (2014)

Effect of A Very Low-Calorie Ketogenic Diet on Food and Alcohol Cravings, Physical and Sexual Activity, Sleep Disturbances, and Quality of Life in Obese Patients
por: Castro, Ana I., et al.
Publicado: (2018)

Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E(2)
por: Kita, Yoshihiro, et al.
Publicado: (2015)

The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
por: Smith, Marie, et al.
Publicado: (2015)

The endocannabinoid 2-arachidonoylglycerol promotes endoplasmic reticulum stress in placental cells
por: Almada, Marta, et al.
Publicado: (2020)

Endocannabinoids, Anandamide and 2-Arachidonoylglycerol, as Prognostic Markers of Sepsis Outcome and Complications
por: Šahinović, Ines, et al.
Publicado: (2023)

A Serious Videogame as an Additional Therapy Tool for Training Emotional Regulation and Impulsivity Control in Severe Gambling Disorder
por: Tárrega, Salomé, et al.
Publicado: (2015)

Endocannabinoids regulate cocaine-associated memory through brain AEA–CB1R signalling activation
por: Li, Hongchun, et al.
Publicado: (2022)

Transdiagnostic Perspective of Impulsivity and Compulsivity in Obesity: From Cognitive Profile to Self-Reported Dimensions in Clinical Samples with and without Diabetes
por: Testa, Giulia, et al.
Publicado: (2021)

Gender-Related Patterns of Emotion Regulation among Patients with Eating Disorders
por: Agüera, Zaida, et al.
Publicado: (2019)

Does ADHD Symptomatology Influence Treatment Outcome and Dropout Risk in Eating Disorders? A longitudinal Study
por: Testa, Giulia, et al.
Publicado: (2020)

Food addiction and lifetime alcohol and illicit drugs use in specific eating disorders
por: Miranda-Olivos, Romina, et al.
Publicado: (2022)

Comparative analysis of distinct phenotypes in gambling disorder based on gambling preferences
por: Moragas, Laura, et al.
Publicado: (2015)

Eating symptomatology and general psychopathology in patients with anorexia nervosa from China, UK and Spain: A cross-cultural study examining the role of social attitudes
por: Agüera, Zaida, et al.
Publicado: (2017)

Eating Disorders and Addictive Behaviors: Implications for Human Health
por: Fernández-Aranda, Fernando, et al.
Publicado: (2023)

Editorial: Neurological, psychological and endocrine markers of eating disorders and obesity
por: Fernández-Aranda, Fernando, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t37onecfhjm6c2t8c0idsv3k96